WSJ: They got cancer, and then their drugs were rationed
University of Cincinnati Cancer Center physician discusses chemotherapy shortage
Across the U.S., a monthslong shortage of critical chemotherapies have forced doctors and pharmacists to stretch their supplies, according to an article in the Wall Street Journal.
Some patients have received less treatment or lengthened the time between treatments, while others have had to turn to second-line options.
The chemotherapies in shortage are cheap, generic drugs that don’t make much profit —and few companies want to manufacture them. After the Food and Drug Administration found quality problems late last year at a major manufacturing facility in India, the company halted its production of two of these drugs, cisplatin and carboplatin, sparking the scarcity.
These (drugs) are the backbones of treatment for many of these cancers, and it is frustrating that this is where we are.
Davendra Sohal University of Cincinnati Cancer Center
At least two dozen patients at the University of Cincinnati Cancer Center have had their treatment disrupted, said Davendra Sohal, MD, an oncologist who treats gastrointestinal cancer patients; he is associate director of clinical research at the Cancer Center. Those already in clinical trials or who can be cured take priority when rationing the drugs, he said, followed by those with progressing disease.
Some patients who are dealing with more stable, chronic disease have had to miss a dose in order to manage the supply, he added. A patient who travels weekly from West Virginia for treatment made the trip last month to find out that there wasn’t any drug, Sohal said. A few weeks ago, only half of the colorectal cancer patients could get their scheduled dose.
“The other half we called and said sorry, not this week,” Sohal said. “These are the backbones of treatment for many of these cancers, and it is frustrating that this is where we are.”
Read the full Wall Street Journal story.
Learn more about the University of Cincinnati Cancer Center.
Featured image at top of Davendra Sohal. Photo credit/UC Health
Innovation Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
How safe is nuclear power proposed for Kentucky?
November 12, 2026
An expert in nuclear energy at the University of Cincinnati helped provide context to listeners of WVXU during a discussion about a nuclear power plant complex proposed along the Ohio River in Eastern Kentucky.
Cincinnati Stride event to help young people who stutter build confidence
November 12, 2026
For children who stutter, speaking can sometimes be frustrating, anxiety-inducing and a source of low confidence. The University of Cincinnati is a host of Cincinnati Stride, formerly Fluency Friday, which gives kids a chance to connect with others who understand what they're going through. Event organizers recently appeared on both WLWT-TV and WKRC-TV to raise awareness ahead of the free workshop.
Pioneer of sports medicine, biomedical engineering invests in UC
November 12, 2026
Fifty years ago, Frank Noyes, MD, and his colleagues understood something not yet obvious to many: the intersection of orthopaedics and biomedical engineering would benefit patients for decades to come.